Pure Global AI
NCT06352164Completed

Efficacy Classification Prediction of the Effects of Acupuncture on Abdominal Pain in Patients With Crohn's Disease

Predicting the Clinical Efficacy of Acupuncture for Abdominal Pain in Patients With Crohn's Disease Based on Gut Microbiology and Machine Learning
Shanghai Institute of Acupuncture, Moxibustion and MeridianClinicalTrials.govother
Verified
Study focus
Disease/Condition
Crohn Disease
Drug/Device/Intervention
Acupuncture treatment
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2015
End date
Mar 31, 2024
Enrollment
55 participants
Primary outcome

Characterisation of gut microflora strains predictive of acupuncture efficacy

Summary

Machine learning algorithms are applied to discover gut flora markers that predict the
 clinical efficacy of acupuncture, so as to screen the appropriate population for acupuncture
 and optimise the allocation of healthcare resources.

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease of small intestineCrohn disease [regional enteritis]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06352164
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06352164 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian and is currently Completed. The study focuses on Crohn Disease. Target enrollment is 55 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.